Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Phase IIb results for the GMZ-2 malaria vaccine in African children

Sep. 23, 2016

The Medicines Company enters strategic partnership with BARDA to develop new antibiotics

Sep. 23, 2016

Cidara Therapeutics selects candidate from immunotherapy discovery platform

Sep. 23, 2016

Entasis Therapeutics reports data from phase II study of EXT-0914

Sep. 23, 2016

Melinta Therapeutics presents antibacterials

Sep. 22, 2016

Sunshine Lake Pharma discloses HCV inhibitors

Sep. 22, 2016

Novel model for the development of phages that target pathogenic bacteria

Sep. 22, 2016

Danish scientists disclose DNA gyrase and topoisomerase IV inhibitors

Sep. 21, 2016

NovaBay Pharmaceuticals' Auriclosene Irrigating Solution shows positive results in phase IIb study

Sep. 20, 2016

Phase II study of CMV vaccine ASP-0113 in kidney transplant patients does not meet primary endpoint

Sep. 20, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...